X-linked adrenoleukodystrophy : Clinical , metabolic , genetic and pathophysiological aspects ☆

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Handbook of clinical neurology

  2013cited by this paper
• SOD2 as a potential modifier of X-linked adrenoleukodystrophy clinical phenotypes

  2012cited by this paper
• CD1 Gene Polymorphisms and Phenotypic Variability in X-Linked Adrenoleukodystrophy

  2012cited by this paper
• Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy

  2011cited by this paper
• X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism.

  2011cited by this paper
• Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy

  2011cited by this paper
• Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-Adrenoleukodystrophy

  2011cited by this paper
• Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patients

  2011cited by this paper
• Adrenoleukodystrophy: Increased plasma content of saturated very long-chain fatty-acids

  2011cited by this paper
• Conservation of targeting but divergence in function and quality control of peroxisomal ABC transporters: an analysis using cross-kingdom expression.

  2011cited by this paper
• Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance

  2011cited by this paper
• Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.

  2011cited by this paper
• Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.

  2011cited by this paper
• Efferent and afferent evoked potentials in patients with adrenomyeloneuropathy.

  2010cited by this paper
• Head trauma can initiate the onset of adreno-leukodystrophy.

  2010cited by this paper
• Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes

  2010cited by this paper
• The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy

  2010influential reference
• Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy

  2010cited by this paper
• Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample

  2009cited by this paper
• Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.

  2009cited by this paper
• Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis.

  2009cited by this paper
• Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: Application to Adrenomyeloneuropathy

  2009cited by this paper
• Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

  2009cited by this paper
• Biochemical Aspects of X‐Linked Adrenoleukodystrophy

  2009influential reference
• Common and rare variants in multifactorial susceptibility to common diseases

  2008cited by this paper
• Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.

  2008cited by this paper
• Oligodendroglial impact on axonal function and survival – a hypothesis

  2008cited by this paper
• Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin

  2008cited by this paper
• X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.

  2008cited by this paper
• Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy.

  2008cited by this paper
• The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters

  2008cited by this paper
• Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture.

  2008cited by this paper
• Is microglial apoptosis an early pathogenic change in cerebral X‐linked adrenoleukodystrophy?

  2008cited by this paper
• [Subtle brain abnormalities in adrenomyeloneuropathy].

  2007cited by this paper
• Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy.

  2007cited by this paper
• Fatty Acid Transport Protein 4 Is the Principal Very Long Chain Fatty Acyl-CoA Synthetase in Skin Fibroblasts*

  2007cited by this paper
• Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes

  2007cited by this paper
• Fatty acid elongases in mammals: their regulation and roles in metabolism.

  2006cited by this paper
• Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy

  2006cited by this paper
• Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings.

  2006cited by this paper
• Diffusion tensor–based imaging reveals occult abnormalities in adrenomyeloneuropathy

  2005cited by this paper
• Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.

  2005cited by this paper
• Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.

  2005cited by this paper
• Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy

  2005cited by this paper
• X-Linked Adrenoleukodystrophy: Genes, Mutations, and Phenotypes

  2004cited by this paper
• Method for measurement of peroxisomal very-long-chain fatty acid beta-oxidation in human skin fibroblasts using stable-isotope-labeled tetracosanoic acid.

  2004cited by this paper
• Functions and biosynthesis of plasmalogens in health and disease.

  2004cited by this paper
• Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.M200340-JLR200

  2003cited by this paper
• Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200363-JLR200

  2003cited by this paper
• Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

  2003cited by this paper
• Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.

  2002cited by this paper
• Eight novel ABCD1 gene mutations and three polymorphisms in patients with X‐linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange

  2001cited by this paper
• Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy

  2001cited by this paper
• ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations

  2001cited by this paper
• Monozygotic twins with X‐linked adrenoleukodystrophy and different phenotypes

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4)

  2001cited by this paper
• Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy

  2000cited by this paper
• Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy.

  1999cited by this paper
• X-linked adrenoleukodystrophy in children: review of genetic, clinical, and MR imaging characteristics.

  1999cited by this paper
• Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.

  1999cited by this paper
• Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.

  1998cited by this paper
• Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis.

  1997cited by this paper
• Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity.

  1997cited by this paper
• Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system.

  1997cited by this paper
• Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system.

  1997cited by this paper
• Reply from the Author

  1996cited by this paper
• Nerve conduction studies in adrenomyeloneuropathy.

  1996cited by this paper
• The ABC transporter proteins Pat1 and Pat2 are required for import of long‐chain fatty acids into peroxisomes of Saccharomyces cerevisiae.

  1996cited by this paper
• Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype

  1996cited by this paper
• Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy.

  1995cited by this paper
• Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles.

  1995cited by this paper
• Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.

  1995cited by this paper
• Adrenoleukodystrophy: the restoration of peroxisomal beta-oxidation by transfection of normal cDNA.

  1995cited by this paper
• X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.

  1994cited by this paper
• Adrenoleukodystrophy: a scoring method for brain MR observations.

  1994cited by this paper
• Lipid and Fatty Acid Composition of Brain Tissue from Adrenoleukodystrophy Patients

  1993cited by this paper
• Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

  1993cited by this paper
• The Inflammatory Myelinopathy of Adreno‐Leukodystrophy: Cells, Effector Molecules, and Pathogenetic Implications

  1992cited by this paper
• Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination.

  1992cited by this paper
• Predictions of a 2-locus model for disease heterogeneity: application to adrenoleukodystrophy.

  1992cited by this paper
• The fatty acid chain elongation system of mammalian endoplasmic reticulum.

  1992cited by this paper
• Fatty Acid Composition of Human Myelin Proteolipid Protein in Peroxisomal Disorders

  1991influential reference
• Cysteine-108 is an acylation site in myelin proteolipid protein.

  1990cited by this paper
• Topography of rat hepatic microsomal enzymatic components of the fatty acid chain elongation system.

  1989cited by this paper
• Fatty acid synthase, a proficient multifunctional enzyme.

  1989cited by this paper
• Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.

  1988cited by this paper
• Lignoceroyl‐CoASH ligase: enzyme defect in fatty acid β‐oxidation system in X‐linked childhood adrenoleukodystrophy

  1986cited by this paper
• The correlation between biochemical and histopathological findings in adrenoleukodystrophy.

  1985cited by this paper
• Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

  1984cited by this paper
• Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.

  1983cited by this paper
• Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.

  1982cited by this paper
• Peroxisomal beta-oxidation of long fatty acids: effects of high fat diets.

  1982cited by this paper
• Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex.

  1981cited by this paper
• Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).

  1981cited by this paper
• Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin.

  1980cited by this paper
• Adreno-leukodystrophy--Sex-linked Schilder disease (先天性機能異常の臨床 )

  1979cited by this paper
• Brain gangliosides in adrenoleukodystrophy.

  1976cited by this paper
• FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHY

  1976cited by this paper
• Histochemical characteristics of the striated inclusions of adrenoleukodystrophy.

  1976cited by this paper

• Living with adrenoleukodystrophy: adult patient and caregiver perspectives

  2026cites this paper
• Molecular insights into sphingomyelin membrane alterations induced by very long-chain lysophospholipids.

  2026cites this paper
• Clinical and radiological characteristics of adult-onset X-linked adrenoleukodystrophy: a Chinese cohort study and review of the literature

  2025cites this paper
• Adrenoleukodystrophy: Current understanding of disease mechanisms, diagnosis, and therapeutic advances-a recent review.

  2025cites this paper
• Overview of genetic mutations causing adrenoleukodystrophy: A case-series study

  2025cites this paper
• X-Linked Adrenoleukodystrophy in a Moroccan Patient: Genetic Diagnosis Leads to Presymptomatic Testing and Family Counseling

  2025cites this paper
• X-linked adrenoleukodystrophy: literature review, description of clinical cases

  2025cites this paper
• Dietary Approaches in the Management of Adrenoleukodystrophy: Evidence Summary for Nutritional Tips

  2025influential citation
• Isolated Leydig cell dysfunction in adrenoleukodystrophy: Rarely reported

  2025cites this paper
• A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms

  2025cites this paper
• Organellar crosstalk as a potential therapeutic target for rare neurodegenerative diseases

  2025cites this paper
• Home-Based Rehabilitation With Frenkel’s Exercises for Adrenomyeloneuropathy: A Case Report

  2025cites this paper
• A Novel Mouse Model for Cerebral Inflammatory Demyelination in X‐Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets

  2024cites this paper
• Spastic paraparesis as a clinical manifestation of severe X-linked adrenoleukodystrophy

  2024cites this paper
• Therapy for X-linked adrenoleukodystrophy

  2024cites this paper
• A novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report

  2024cites this paper
• Protective effect of oleic acid against very long-chain fatty acid-induced apoptosis in peroxisome-deficient CHO cells.

  2024cites this paper
• Burden of illness and mortality in men with Adrenomyeloneuropathy: a retrospective cohort study

  2024cites this paper
• Central precocious puberty in a boy with X-linked adrenoleukodystrophy caused by a novel ABCD1 mutation

  2024cites this paper
• Hereditary spastic paraplegia and extensive leukoencephalopathy: a case report of a unique phenotype associated with a GJB1/Cx32 p.Pro174Ser variant

  2024cites this paper
• Practical Approach to Longitudinal Neurologic Care of Adults With X-Linked Adrenoleukodystrophy and Adrenomyeloneuropathy

  2024cites this paper
• The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology

  2024cites this paper
• Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening

  2024cites this paper
• Pathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms

  2024cites this paper
• Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective

  2023influential citation
• Vitamin D status and latitude predict brain lesions in adrenoleukodystrophy

  2023influential citation
• Initial frontal lobe involvement in adult cerebral X-linked adrenoleukodystrophy

  2023cites this paper
• Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms.

  2023cites this paper
• Microstructural Changes in Normal-Appearing White Matter in Pediatric X-Linked Adrenoleukodystrophy: A Diffusion Tensor Imaging Study

  2023cites this paper
• Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate

  2023cites this paper
• Generation of induced pluripotent stem line (MIPTi001-A) derived from patient with X-linked adrenoleukodystrophy (X-ALD).

  2023cites this paper
• Novel mutations in the ABCD1 gene caused adrenomyeloneuropathy in the Chinese population

  2023cites this paper
• Molecular species profiles of plasma ceramides in different clinical types of X-linked adrenoleukodystrophy.

  2023cites this paper
• X-linked adrenoleukodystrophy and primary adrenal insufficiency

  2023cites this paper
• A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0- lysophosphatidylcholine in dried blood spots: results from 43,653 newborns in a southern Chinese population.

  2023cites this paper
• Rehabilitation of a 17-year-old patient with x-linked adrenoleukodystrophy

  2022cites this paper
• Leucoencefalopatie ereditarie e leucodistrofie dell’adulto

  2022cites this paper
• Bile acids and neurological disease.

  2022cites this paper
• Progressive Cognitive and Behavioral Changes With Leukodystrophy due to ABCD1 Gene Mutation

  2022cites this paper
• Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy

  2022cites this paper
• Peroxisomes attenuate cytotoxicity of very long-chain fatty acids.

  2022cites this paper
• Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series.

  2022cites this paper
• Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy

  2022cites this paper
• Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations

  2022cites this paper
• Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model

  2022influential citation
• Newborn Screen for X-Linked Adrenoleukodystrophy Using Flow Injection Tandem Mass Spectrometry in Negative Ion Mode

  2022cites this paper
• Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort

  2022cites this paper
• Long-Term Disease Prevention with a Gene Therapy Targeting Oligodendrocytes in a Mouse Model of Adrenomyeloneuropathy

  2022cites this paper
• Leucoencéphalopathies et leucodystrophies héréditaires de l’adulte

  2022cites this paper
• Effects of a Short-Term Lipopolysaccharides Challenge on Mouse Brain and Liver Peroxisomal Antioxidant and β-oxidative Functions: Protective Action of Argan Oil

  2022cites this paper
• Peroxisomes in intracellular cholesterol transport: from basic physiology to brain pathology

  2021cites this paper
• Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia

  2021cites this paper
• Genetic analysis and prenatal diagnosis of 76 Chinese families with X‐linked adrenoleukodystrophy

  2021cites this paper
• Characterization of uptake and metabolism of very long-chain fatty acids in peroxisome-deficient CHO cells.

  2021cites this paper
• Translational and clinical pharmacology considerations in drug repurposing for X‐linked adrenoleukodystrophy—A rare peroxisomal disorder

  2021cites this paper
• Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement

  2021cites this paper
• Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord

  2021cites this paper
• N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

  2021cites this paper
• iBRET Screen of the ABCD1 Peroxisomal Network and Mutation-Induced Network Perturbations.

  2021cites this paper
• The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy

  2021cites this paper
• A Large Family with p.Arg554His Mutation in ABCD1: Clinical Features and Genotype/Phenotype Correlation in Female Carriers

  2021influential citation
• Genetic Aetiology of Primary Adrenal Insu�ciency in Chinese Children

  2021cites this paper
• Attenuation of 7-ketocholesterol- and 7β-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: potential for the prevention of age-related diseases.

  2021cites this paper
• Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity

  2021cites this paper
• Peroxisomal Metabolite and Cofactor Transport in Humans

  2021cites this paper
• Dosage Compensation in Females with X-Linked Metabolic Disorders

  2021cites this paper
• First reported adult patient with retinal dystrophy and leukodystrophy caused by a novel ACBD5 variant: A case report and review of literature

  2021influential citation
• Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases

  2021cites this paper
• ABCD1 gene mutation in an Italian family with X-linkedadrenoleukodystrophy: case series

  2021cites this paper
• Beyond gait and balance: urinary and bowel dysfunction in X-linked adrenoleukodystrophy

  2021cites this paper
• Generation of an immortalized astrocytic cell line from Abcd1-deficient H-2KbtsA58 mice to facilitate the study of the role of astrocytes in X-linked adrenoleukodystrophy

  2021cites this paper
• Peroxisomes form intralumenal vesicles with roles in fatty acid catabolism and protein compartmentalization in Arabidopsis

  2020cites this paper
• X-Linked Adrenoleukodystrophy: Report of an atypical case

  2020cites this paper
• Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275

  2020cites this paper
• Novel Pathogenic Variant of X-Linked Adrenoleukodystrophy in Mother of Affected Boys: Better Late Than Never

  2020cites this paper
• Acute coronary syndrome with ST segment elevation in a patient with Addison disease: Case report and brief review of physiopathological mechanisms: A case study

  2020cites this paper
• Membrane organization | Lipid Transporters: Flippases, Floppases and Scramblases

  2020cites this paper
• Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy

  2020cites this paper
• A 29-year-old patient with adrenoleukodystrophy presenting with Addison's disease.

  2020cites this paper
• Clinical, Neuroimaging, Biochemical, and Genetic Features in Cases of Chinese Patients with Adrenomyeloneuropathy

  2020cites this paper
• Genetic aetiology of primary adrenal insufficiency in Chinese children

  2020cites this paper
• Developmental and Degenerative Cerebellar Pathologies in Peroxisomal β-Oxidation Deficiency.

  2020cites this paper
• Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina

  2020cites this paper
• Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy

  2020cites this paper
• Lipids in the Physiopathology of Hereditary Spastic Paraplegias

  2020cites this paper
• Peroxisome Assembly, Degradation, and Disease

  2020cites this paper
• Genetic Aetiology of Primary Adrenal Insu�ciency in Chinese Children

  2020cites this paper
• Atypical image presentation of X-linked adrenoleukodystrophy

  2020cites this paper
• X‐Linked Adrenoleukodystrophy Mimicking Hereditary Spastic Paraplegia

  2020cites this paper
• A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy

  2019cites this paper
• Clinical characteristics and phenotype distribution in 10 Chinese patients with X-linked adrenoleukodystrophy

  2019cites this paper
• Biogenesis and Function of Peroxisomes in Human Disease with a Focus on the ABC Transporter.

  2019cites this paper
• Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy

  2019cites this paper
• Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.

  2019cites this paper
• Exogenous Addition of 25‐Hydroxycholesterol Reduces Level of Very Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy

  2019cites this paper
• Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases

  2019cites this paper
• X-linked adrenoleukodystrophy presenting as isolated spastic paraparesia

  2019cites this paper
• Lessons Learned from Newborn Screening in Pilot Studies

  2019cites this paper
• Visual loss as first clinical manifestation of X-linked adrenoleukodystrophy

  2019cites this paper
• The Role of a Fatty Acid Chain Elongase, Elovl1, in Zebrafish and Its Implications for Kidney Disease in Humans

  2019cites this paper